InsiderClue
← All stocks

Immunome Inc.

IMNM Net buying
CIK 0001472012 #1696 in the set updated 17 Sep 2026
Bought (12 mo)
$2.31M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$27.51M
$18.48M on a plan · $7.49M straight out of an exercise
Sold at will
$1.54M
4 of 28 sales
Net
−$25.20M
+$766.54K against sales at will

By person

10 insiders · 39 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Barchas Isaac
Director
—
$18.27M (12) scheduled
−$18.27M
92,211
0.0812%
$2.33M
−89.7%
Rosett Max
Chief Financial Officer
—
$2.52M (3) scheduled
−$2.52M
101,287
0.0892%
$2.56M
+410.1%
Lechleider Robert
Chief Medical Officer
—
$2.34M (5) scheduled
−$2.34M
69,805
0.0615%
$1.77M
—
Horn Kinney
CHIEF BUSINESS OFFICER
—
$2.30M (2) scheduled
−$2.30M
0
0.0000%
$0.00
—
SIEGALL CLAY B
President and CEO
$1.75M (4)
—
+$1.75M
870,704
0.7666%
$22.05M
+107.5%
WAGENHEIM PHILIP
Director
—
$1.34M (2)
−$1.34M
341,147
0.3004%
$8.64M
−16.0%
Higgins Jack
Chief Scientific Officer
—
$538.46K (2) scheduled
−$538.46K
60,250
0.0530%
$1.53M
+314.7%
Tsai Philip
Chief Technical Officer
$204.90K (1)
—
+$204.90K
81,550
0.0718%
$2.06M
—
BIENAIME JEAN JACQUES
Director
$351.43K (6)
$203.82K (2)
+$147.61K
43,415
0.0382%
$1.10M
+161.3%
Stoneman Sandra G.
CHIEF LEGAL OFFICER & GC
—
—
—
43,805
0.0386%
$1.11M
+688.6%

Individual transactions

4
Insider
Date
Role
Action
Shares
Price
Amount
BIENAIME JEAN JACQUES
5 Jun 2026
Director
Sell
10,000
$19.41
$194.10K
BIENAIME JEAN JACQUES
5 Jun 2026
Director
Sell
500
$19.44
$9.72K
WAGENHEIM PHILIP
23 Mar 2026
Director
Sell
28,200
$20.65
$582.33K
WAGENHEIM PHILIP
20 Mar 2026
Director
Sell
36,800
$20.47
$753.30K
Show all 39 transactions →

What was left out

Form 4 filings counted 37
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 11
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 999,610
History held since 5 Oct 2020